Cabaletta Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
PHILADELPHIA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery...
PHILADELPHIA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery...
NEW HAVEN, Conn., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on...
Continued to enroll and dose patients in Phase 1/2 clinical trial of BDTX-189, with Phase 1 portion on track to...
SAN JOSE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
- Completed Initial Public Offering of Common Stock, Raising Gross Proceeds of ~$181.9M - - Partial Response Confirmed in Glioblastoma...
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to...
NEW YORK--(BUSINESS WIRE)--Genosity, Inc., an innovative biotechnology company that provides comprehensive software and laboratory solutions to enable precision medicine, announced...
Combination and Investment to Drive Growth of Industry-Leading Surgery Center Software Solutions LAFAYETTE, Calif. & BOSTON--(BUSINESS WIRE)--#ASC--HST Pathways (“HST”) and...
BOSTON--(BUSINESS WIRE)--Cohealo, the first sharing economy company in healthcare, today announced a contract with Vizient, the nation's largest member driven...
Highlights How COVID-19 Has Forced Patient Access Leadership to Focus on Their Digital Patient Experience BOSTON--(BUSINESS WIRE)--Lumeon, the leader in...
Patients experienced significant clinical benefits and satisfaction with recharging and therapy Clinical outcomes consistent with dual incontinence patients from ARSTISAN...
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term,...
Energy Capital to Provide up to $12 Million of Liquidity GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical...
Procedure Numbers Consistent with 2019 Levels Cash and Cash Equivalents of $42.7 Million as of September 30, 2020 ORLANDO, Fla.--(BUSINESS...
MURFREESBORO, TN / ACCESSWIRE / November 9, 2020 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the...
ST. LOUIS PARK, MN / ACCESSWIRE / November 9, 2020 / Sholom, based in St. Louis Park, MN, is pleased...
-New clinical trial collaborations with pharmaceutical companies on track to close -Cash burn rate steady -Cash and cash equivalents of...
WALTHAM, MA / ACCESSWIRE / November 9, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company...
INDIANAPOLIS, IN / ACCESSWIRE/ November 9, 2020 / Have you heard of the artificial retina? This cutting edge field could...